Evidence map›Paper›PMID 28771614›Full record

ArticlePloS one2017

TREM-1 SNP rs2234246 regulates TREM-1 protein and mRNA levels and is associated with plasma levels of L-selectin.

Alex-Ander Aldasoro Arguinano, Sébastien Dadé, Maria Stathopoulou, Marc Derive, Ndeye Coumba Ndiaye, Ting Xie, Christine Masson, Sébastien Gibot, Sophie Visvikis-Siest

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 25 citations in OpenAlex.

  1. Observational
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Frontiers in immunology · 2020
    Article
  13. Article
  14. TREM-1; Is It a Pivotal Target for Cardiovascular Diseases?Journal of cardiovascular development and disease · 2018
    Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Alex-Ander Aldasoro ArguinanoUMR INSERM U1122; IGE-PCV 'Interactions Gène-Environnement en Physiopathologie Cardiovasculaire', Faculté de Pharmacie-Université de Lorraine, Nancy, France.
Sébastien DadéUMR INSERM U1122; IGE-PCV 'Interactions Gène-Environnement en Physiopathologie Cardiovasculaire', Faculté de Pharmacie-Université de Lorraine, Nancy, France.
Maria StathopoulouUMR INSERM U1122; IGE-PCV 'Interactions Gène-Environnement en Physiopathologie Cardiovasculaire', Faculté de Pharmacie-Université de Lorraine, Nancy, France.
Marc DeriveINOTREM, Nancy, France.
Ndeye Coumba NdiayeUMR INSERM U1122; IGE-PCV 'Interactions Gène-Environnement en Physiopathologie Cardiovasculaire', Faculté de Pharmacie-Université de Lorraine, Nancy, France.
Ting XieUMR INSERM U1122; IGE-PCV 'Interactions Gène-Environnement en Physiopathologie Cardiovasculaire', Faculté de Pharmacie-Université de Lorraine, Nancy, France.
Christine MassonUMR INSERM U1122; IGE-PCV 'Interactions Gène-Environnement en Physiopathologie Cardiovasculaire', Faculté de Pharmacie-Université de Lorraine, Nancy, France.
Sébastien GibotRéanimation Médicale, Hôpital Central, Nancy, France.
Sophie Visvikis-SiestUMR INSERM U1122; IGE-PCV 'Interactions Gène-Environnement en Physiopathologie Cardiovasculaire', Faculté de Pharmacie-Université de Lorraine, Nancy, France.ORCID http://orcid.org/0000-0001-8104-8425
Inserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

High levels of TREM-1 are associated with cardiovascular and inflammatory diseases risks and the most recent studies have showed that TREM-1 deletion or blockade is associated with up to 60% reduction of the development of atherosclerosis. So far, it is unknown whether the levels of TREM-1 protein are genetically regulated. Moreover, TREM family receptors have been suggested to regulate the cellular adhesion process. The goal of this study was to investigate whether polymorphisms within TREM-1 are regulating the variants of serum TREM-1 levels and the expression levels of their mRNA. Furthermore, we aimed to point out associations between polymorphisms on TREM-1 and blood levels of selectins. Among the 10 SNPs studied, the minor allele T of rs2234246, was associated with increased sTREM-1 in the discovery population (p-value = 0.003), explaining 33% of its variance, and with increased levels of mRNA (p-value = 0.007). The same allele was associated with increased soluble L-selectin levels (p-value = 0.011). The higher levels of sTREM-1 and L-selectin were confirmed in the replication population (p-value = 0.0007 and p-value = 0.018 respectively). We demonstrated for the first time one SNP on TREM-1, affecting its expression levels. These novel results, support the hypothesis that TREM-1 affects monocytes extravasation and accumulation processes leading to atherogenesis and atherosclerotic plaque progression, possibly through increased inflammation and subsequent higher expression of sL-selectin.

Indexed as

AdultAlternative SplicingAtherosclerosisBinding SitesFemaleGene Expression RegulationGene FrequencyGenotypeHumansLeukocytes, MononuclearL-SelectinMaleMembrane GlycoproteinsMiddle AgedMonocytesPolymorphism, Single NucleotideL-SelectinMembrane GlycoproteinsProtein IsoformsReceptors, ImmunologicRNA, MessengerTranscription FactorsTREM1 protein, humanTriggering Receptor Expressed on Myeloid Cells-1

Identifiers

PMID28771614
PMCPMC5542552
OpenAlexW2743462882

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.